{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:33:40Z","timestamp":1762522420864},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>On March 11th, 2020 the World Health Organization declared COVID-19 a global pandemic. The infection, transmitted by 2019 novel coronavirus (2019-nCov), was first discovered in December 2019, in Wuhan, Hubei Province, and then rapidly spread worldwide. Italy was early and severely involved, with a critical spread of the infection and a very high number of victims. Person-to-person spread mainly occurs via respiratory droplets and contact. The median incubation period is 5\u2009days. The spectrum of respiratory symptoms may range from mild to severe, strictly depending on the age of the patient and the underlying comorbidities.<\/jats:p><jats:p>In children COVID-19 related disease is less frequent and less aggressive. In Italy 1% of positive cases are under 18\u2009years of age, and no deaths have been recorded before 29\u2009years of age. For patients affected by rheumatic disease, despite the concerns related to the imbalance of their immune response and the effect of immunosuppressive treatments, there are still few data to understand the real consequences of this infection. Major scientific societies have issued recommendations to help rheumatologists in caring their patients. Interestingly, some of the drugs mostly used by rheumatologists appear to be promising in critical COVID-19 infected patients, where the hyperinflammation and cytokine storm seem to drive to the multiorgan failure.<\/jats:p><jats:p>Pediatric rheumatologists are expected to play a supporting role in this new front of<jats:italic>COVID<\/jats:italic>-19 pandemic, both as general pediatricians treating infected children, and as rheumatologists taking care of their rheumatic patients, as well as offering their experience in the possible alternative use of immunomodulatory drugs.<\/jats:p>","DOI":"10.1186\/s12969-020-00422-z","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T16:03:42Z","timestamp":1587571422000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country"],"prefix":"10.1186","volume":"18","author":[{"given":"Francesco","family":"Licciardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Giani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ennio Giulio","family":"Favalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Caporali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Cimaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"key":"422_CR1","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020 (in press)."},{"key":"422_CR2","doi-asserted-by":"crossref","unstructured":"Zhao S, Lin Q, Ran J, Musa SS, Guangpu Yang G, Wang W et al. 2020. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-NCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis 2020; 92:214\u2013217.","DOI":"10.1016\/j.ijid.2020.01.050"},{"key":"422_CR3","unstructured":"Ministero della Salute: Nuovo Coronavirus la situazione in Italia http:\/\/www.salute.gov.it\/portale\/nuovocoronavirus\/homeNuovoCoronavirus.html. ."},{"issue":"10223","key":"422_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","volume":"395","author":"JF Chan","year":"2020","unstructured":"Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514\u201323.","journal-title":"Lancet."},{"key":"422_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2807\/1560-7917.ES.2020.25.10.2000180","volume":"25","author":"K Mizumoto","year":"2020","unstructured":"Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020;25:10.","journal-title":"Euro Surveill"},{"issue":"7798","key":"422_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270\u20133.","journal-title":"Nature."},{"key":"422_CR7","doi-asserted-by":"publisher","unstructured":"Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020. https:\/\/doi.org\/10.1038\/s41564-020-0688-y.","DOI":"10.1038\/s41564-020-0688-y"},{"key":"422_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","volume":"1282","author":"AR Fehr","year":"2015","unstructured":"Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1\u201323.","journal-title":"Methods Mol Biol"},{"issue":"10223","key":"422_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"key":"422_CR10","doi-asserted-by":"publisher","unstructured":"Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol. 2020. https:\/\/doi.org\/10.1016\/j.meegid.2020.104212.","DOI":"10.1016\/j.meegid.2020.104212"},{"issue":"5748","key":"422_CR11","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1126\/science.1118391","volume":"310","author":"W Li","year":"2005","unstructured":"Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science. 2005;310(5748):676\u20139.","journal-title":"Science."},{"issue":"2","key":"422_CR12","first-page":"139","volume":"41","author":"Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association","year":"2020","unstructured":"Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association. An Update on the Epidemiological Characteristics of Novel Coronavirus Pneumonia COVID-19. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):139\u201344.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"4","key":"422_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/jmv.25682","volume":"92","author":"W Ji","year":"2020","unstructured":"Ji W, Wang W, Zhao X, Zai J, Li X. Cross-species transmission of the newly identified coronavirus 2019-nCoV. J Med Virol. 2020;92(4):433\u201340.","journal-title":"J Med Virol"},{"key":"422_CR14","doi-asserted-by":"crossref","unstructured":"Xiao K, Zhai J, Feng Y, Zhou N, Zhang X, Zou JJ, et al. Isolation and characterization of 2019-NCoV-like coronavirus from Malayan pangolins. BioRxiv. 2020.","DOI":"10.1101\/2020.02.17.951335"},{"key":"422_CR15","doi-asserted-by":"crossref","unstructured":"Liu P, Jiang JZ, Hua Y, Wang X, Hou F, Wan XF et al. Are Pangolins the Intermediate Host of the 2019 Novel coronavirus (2019-NCoV)? BioRxiv 2020.","DOI":"10.1101\/2020.02.18.954628"},{"key":"422_CR16","doi-asserted-by":"publisher","unstructured":"Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H, et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020. https:\/\/doi.org\/10.1002\/jmv.25726.","DOI":"10.1002\/jmv.25726"},{"key":"422_CR17","doi-asserted-by":"crossref","unstructured":"Zhang C, Zheng W, Huang X, Bell EW, Zhou X, Zhang Y. Protein structure and sequence re-analysis of 2019-NCoV genome does not indicate snakes as its intermediate host or the unique similarity between its spike protein insertions and HIV-1. BioRxiv. 2020.","DOI":"10.1101\/2020.02.04.933135"},{"key":"422_CR18","doi-asserted-by":"crossref","unstructured":"Guo Q, Li M, Wang C, Fang Z, Wang P, Tan J, et al. Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm. BioRxiv. 2020.","DOI":"10.1101\/2020.01.21.914044"},{"key":"422_CR19","doi-asserted-by":"publisher","unstructured":"Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020. https:\/\/doi.org\/10.1001\/jama.2020.2565.","DOI":"10.1001\/jama.2020.2565"},{"issue":"10","key":"422_CR20","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1056\/NEJMc2001468","volume":"382","author":"C Rothe","year":"2020","unstructured":"Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970\u20131.","journal-title":"N Engl J Med"},{"issue":"10226","key":"422_CR21","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0140-6736(20)30360-3","volume":"395","author":"H Chen","year":"2020","unstructured":"Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809\u201315.","journal-title":"Lancet."},{"key":"422_CR22","doi-asserted-by":"publisher","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMoa2002032.","DOI":"10.1056\/NEJMoa2002032"},{"key":"422_CR23","doi-asserted-by":"publisher","unstructured":"Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMoa2001316.","DOI":"10.1056\/NEJMoa2001316"},{"issue":"10223","key":"422_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313.","journal-title":"Lancet"},{"key":"422_CR25","doi-asserted-by":"publisher","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020. https:\/\/doi.org\/10.1001\/jama.2020.1585.","DOI":"10.1001\/jama.2020.1585"},{"key":"422_CR26","doi-asserted-by":"publisher","unstructured":"Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. 2020. https:\/\/doi.org\/10.1148\/radiol.2020200463.","DOI":"10.1148\/radiol.2020200463"},{"issue":"1","key":"422_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1148\/radiol.2020200241","volume":"295","author":"JP Kanne","year":"2020","unstructured":"Kanne JP, Chest CT. Findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist. Radiology. 2020;295(1):16\u20137.","journal-title":"Radiology."},{"key":"422_CR28","doi-asserted-by":"publisher","unstructured":"Rodriguez-Morales AJ, Cardona-Ospina JA, Guti\u00e9rrez-Ocampo E, Villamizar-Pe\u00f1a R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101623.","DOI":"10.1016\/j.tmaid.2020.101623"},{"key":"422_CR29","doi-asserted-by":"publisher","unstructured":"Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa270.","DOI":"10.1093\/cid\/ciaa270"},{"key":"422_CR30","doi-asserted-by":"publisher","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020. https:\/\/doi.org\/10.1007\/s00134-020-05991-x.","DOI":"10.1007\/s00134-020-05991-x"},{"key":"422_CR31","doi-asserted-by":"publisher","unstructured":"Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020. https:\/\/doi.org\/10.1542\/peds.2020-0702.","DOI":"10.1542\/peds.2020-0702"},{"key":"422_CR32","doi-asserted-by":"publisher","unstructured":"Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults. Pediatr Pulmonol. 2020. https:\/\/doi.org\/10.1002\/ppul.24718.","DOI":"10.1002\/ppul.24718"},{"key":"422_CR33","doi-asserted-by":"publisher","unstructured":"Henry BM, Lippi G, Plebani M. Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Chem Lab Med. 2020. https:\/\/doi.org\/10.1515\/cclm-2020-0272.","DOI":"10.1515\/cclm-2020-0272"},{"key":"422_CR34","doi-asserted-by":"publisher","unstructured":"Li W, Cui H, Li K, Fang Y, Li S. Chest computed tomography in children with COVID-19 respiratory infection. Pediatr Radiol. 2020. https:\/\/doi.org\/10.1007\/s00247-020-04656-7.","DOI":"10.1007\/s00247-020-04656-7"},{"key":"422_CR35","doi-asserted-by":"publisher","unstructured":"Lu Q, Shi Y. Coronavirus disease (COVID-19) and neonate: what neonatologist need to know. J Med Virol. 2020. https:\/\/doi.org\/10.1002\/jmv.25740.","DOI":"10.1002\/jmv.25740"},{"issue":"2","key":"422_CR36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/1744666X.2019.1550359","volume":"15","author":"A Marino","year":"2019","unstructured":"Marino A, Giani T, Cimaz R. Risks associated with use of TNF inhibitors in children with rheumatic diseases. Expert Rev Clin Immunol. 2019;15(2):189\u201398.","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"422_CR37","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1002\/art.34458","volume":"64","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG, et al. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 2012;64(8):2773\u201380.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"422_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13075-016-1109-8","volume":"18","author":"T Beukelman","year":"2016","unstructured":"Beukelman T, Xie F, Baddley JW, Chen L, Mannion ML, Saag KG, et al. The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis. Arthritis Res Ther. 2016;18(1):210.","journal-title":"Arthritis Res Ther"},{"key":"422_CR39","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1002\/art.39197","volume":"67","author":"R Davies","year":"2015","unstructured":"Davies R, Southwood TR, Kearsley-Fleet L, Lunt M, Hyrich KL. Medically significant infections are increased in patients with juvenile idiopathic arthritis treated with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study. Arthritis Rheum. 2015;67:2487\u201394.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"422_CR40","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/acr.22961","volume":"69","author":"I Becker","year":"2017","unstructured":"Becker I, Horneff G. Risk of serious infection in juvenile idiopathic arthritis patients associated with TNF-inhibitors and disease activity in the German BIKER registry. Arthritis Care Res. 2017;69(4):552\u201360.","journal-title":"Arthritis Care Res"},{"issue":"2","key":"422_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/rheumatology\/kex049","volume":"57","author":"WJ Lee","year":"2018","unstructured":"Lee WJ, Lee TA, Suda KJ, Calip GS, Briars L, Schumock GT. Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis. Rheumatology (Oxford). 2018;57(2):273\u201382.","journal-title":"Rheumatology (Oxford)"},{"key":"422_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1546-0096-11-10","volume":"11","author":"LM Carvalho","year":"2013","unstructured":"Carvalho LM, De Paula FE, Silvestre RVD, Roberti LR, Arruda E, Mello WA, et al. Prospective surveillance study of acute respiratory infections, influenza-like illness and seasonal influenza vaccine in a cohort of juvenile idiopathic arthritis patients. Pediatr Rheumatol. 2013;11:10.","journal-title":"Pediatr Rheumatol"},{"issue":"3","key":"422_CR43","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00296-014-3197-6","volume":"35","author":"S Nimmrich","year":"2015","unstructured":"Nimmrich S, Horneff G. Incidence of herpes zoster infections in juvenile idiopathic arthritis patients. Rheumatol Int. 2015;35(3):465\u201370.","journal-title":"Rheumatol Int"},{"issue":"1","key":"422_CR44","first-page":"118","volume":"31","author":"YH Lee","year":"2013","unstructured":"Lee YH, Bae SC, Song GG. Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-TNF therapy. Clin Exp Rheumatol. 2013;31(1):118\u201321.","journal-title":"Clin Exp Rheumatol"},{"key":"422_CR45","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.3346\/jkms.2020.35.e79","volume":"35","author":"J Lim","year":"2020","unstructured":"Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, et al. Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of Lopinavir\/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J Korean Med Sci. 2020;35:e79.","journal-title":"J Korean Med Sci"},{"key":"422_CR46","unstructured":"World Health Organization. Clinical management of severe acute respiratory infection when Novel coronavirus (2019-nCoV) infection is suspected: Interim Guidance. 2020."},{"key":"422_CR47","doi-asserted-by":"publisher","unstructured":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of Lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMoa2001282.","DOI":"10.1056\/NEJMoa2001282"},{"key":"422_CR48","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269\u201371.","journal-title":"Cell Res"},{"key":"422_CR49","doi-asserted-by":"publisher","unstructured":"Touret F, de Lamballerie X. Of chloroquine and COVID-19. Antivir Res. 2020. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104762.","DOI":"10.1016\/j.antiviral.2020.104762"},{"key":"422_CR50","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","volume":"323","author":"E Keyaerts","year":"2004","unstructured":"Keyaerts E, Vijgen L, Maes P, Neyts J, Ranst MV. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Bioph Res Co. 2004;323:264\u20138.","journal-title":"Biochem Bioph Res Co"},{"key":"422_CR51","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","volume":"6","author":"J Liu","year":"2020","unstructured":"Liu J, Cao R, Xu M, Wang X, Zhang H, Hu H, et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020;6:16.","journal-title":"Cell Discov"},{"key":"422_CR52","doi-asserted-by":"crossref","unstructured":"Zhou D, Dai SM, Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother. 2020.","DOI":"10.1093\/jac\/dkaa114"},{"key":"422_CR53","first-page":"91","volume":"25","author":"B Kazzi","year":"2018","unstructured":"Kazzi B, Lederer D, Arteaga-Solis E, Saqi A, Chung WK. Recurrent diffuse lung disease due to surfactant protein C deficiency. Respir Med Case Rep. 2018;25:91\u20135.","journal-title":"Respir Med Case Rep"},{"key":"422_CR54","doi-asserted-by":"publisher","unstructured":"Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.","DOI":"10.1016\/j.ijantimicag.2020"},{"key":"422_CR55","doi-asserted-by":"publisher","unstructured":"Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020. https:\/\/doi.org\/10.5582\/bst.2020.01047.","DOI":"10.5582\/bst.2020.01047"},{"key":"422_CR56","doi-asserted-by":"publisher","unstructured":"Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa237.","DOI":"10.1093\/cid\/ciaa237"},{"key":"422_CR57","doi-asserted-by":"publisher","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"422_CR58","unstructured":"Xu X, Han M, Li T, Sun W, Wang D, Fu B et al. Effective treatment of Severe COVID-19 patients with tocilizumab. ChinaXiv: 2020 03.00026v1."},{"key":"422_CR59","unstructured":"A phase 2\/3, randomized, open-label, parallel group, 3-arm, multicenter study investigating the efficacy and safety of intravenous administrations of emapalumab, an anti-interferon gamma (anti- IFN\u03b3) monoclonal antibody, and anakinra, an interleukin-1(IL-1) receptor antagonist, versus standard of care, in reducing hyper-inflammation and respiratory distress in patients with SARSCoV-2 infection. Final Protocol Number: Sobi.IMMUNO-101. EudraCT Number: 2020-001167-93."},{"key":"422_CR60","unstructured":"https:\/\/dgsurgent.sante.gouv.fr\/dgsurgent\/inter\/detailsMessageBuilder.do?id=30500&cmd=visualiserMessage Accessed 24 Mar 2020."},{"issue":"8","key":"422_CR61","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/135965350601100803","volume":"11","author":"C Amici","year":"2006","unstructured":"Amici C, Di Caro A, Ciucci A, Chiappa L, Castilletti C, Martella V, et al. Indomethacin has a potent antiviral activity against SARS coronavirus. Antivir Ther. 2006;11(8):1021\u201330.","journal-title":"Antivir Ther"},{"key":"422_CR62","doi-asserted-by":"publisher","unstructured":"Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R. COVID-19 infection and rheumatoid arthritis: faraway, so close! Autoimmun rev. 2020; https:\/\/doi.org\/10.1016\/j.autrev.2020.102523.","DOI":"10.1016\/j.autrev.2020.102523"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-020-00422-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-020-00422-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-020-00422-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T01:56:35Z","timestamp":1666403795000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-020-00422-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["422"],"URL":"https:\/\/doi.org\/10.1186\/s12969-020-00422-z","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]},"assertion":[{"value":"27 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors report no potential conflicts.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}